Floatz logo

Levetiracetam

Epilepsy With Generalized Tonic-Clonic Seizures

Emory UniversitySmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Epilepsy With Generalized Tonic-Clonic Seizures cohort.

Asset / SponsorPhaseRating
LAMOTRIGINE
GlaxoSmithKline
Phase 4BBB
Topiramate
GlaxoSmithKline
Phase 3BB
MIDAZOLAM
Pakistan Air Force (PAF) Hospital Islamabad
Phase 4BB
Pregabalin
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 3BB
Zonisamide
Affiliated Hospital of Nantong University
Phase 4B

View all 12 →

Same molecule, other indications

Levetiracetam is also rated in:

epilepsyActive
BBB
Indicative · Phase 4
74 / 100
View asset →
acute lymphoblastic leukemiaActive
CCC
Indicative · Phase 2
51 / 100
View asset →
acute myeloid leukemiaActive
CCC
Indicative · Phase 2
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →